Mirella Nardo

7PUBLICATIONS
40CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)ClinimetricsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 11, 2025
Pembrolizumab in Patients with Advanced Miscellaneous Rare Cancers: Results from a Phase 2 Basket Trial.

Mirella Nardo, Camila Braganca Xavier, Bettzy Stephen

|Nov 05, 2024
Real-World Comparative Analysis of Liposomal Doxorubicin Versus Paclitaxel as First-Line Therapy for Kaposi Sarcoma.

Mariana Carvalho Gouveia, Heloisa Guedes Andrade, Cassio Murilo Hidalgo Filho

|Sep 02, 2024
Phase 1 Clinical Trials: Challenges and Opportunities in Latin America.

Mirella Nardo, Camila Bragança Xavier, Fabio Franke

|Apr 30, 2024
Clinical and Genomic Landscape of RAS Mutations in Gynecologic Cancers.

Ji Son, Yingao Zhang, Heather Lin

|May 25, 2023
Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma.

Blessie Elizabeth Nelson, Neha K Reddy, Jason T Huse

Pageof 2